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ABSTRACT  Several properties  of the enzyme  acetylcholinestcrasc  (ACHE) 
isolated in vitro arc compared with those of the membrane  receptor(s)  of 
acctylcholinc expressed by the in vivo electrical  response of the clcctroplax 
membrane. AChE  strongly  binds in vitro  cffcctors  of the clcctroplax:  agonists 
e.g., dccamcthonium  or antagonism, e.g., d-tubocurarinc and  flaxcdil. It 
also reacts  covalcntly  with an affinity  labeling  reagent of the acctylcholinc 
receptor  site(s)  in vivo (TDF). Two classes  of  sites  on AChE molecule account 
for the binding of these  quaternary nitrogen containing compounds: (I) the 
anionic site of the active center and  (2) noncatalytlc "peripheral anionic 
centers" located outside the active  center.  A  disulfide  bond breaking agent, 
dithiothrcitol  (DTT) alters  in a parallel  manner the reaction  of AChE  and 
the excitable  membrane  of the clcctroplax to TDF.  The irrcvcrsibility  of 
TDF  action  is lost  in both cases,  after  exposure to DTT. Both AChE  and the 
acctylcholinc  receptor thus  contain  disulfide  bonds--they arc closely  related 
but not necessarily  identical  proteins. 
Acetylcholine (ACh) is a general, although not necessarily unique, effcctor 
of  excitable rncrnbrancs (Nachmansohn,  1959, 1968). In the animal kingdom 
a  considerable  number  of  ccUs--rnuscular,  glandular,  neuronal,  etc.-- 
respond to  ACh  binding by a characteristic  change of  rncrnbranc permeability. 
An essential  feature of the effect  of  ACh  and its congeners is that it does not 
involve as a necessary step any covalent or catalytic  reaction: ACh  acts  as 
a regulatory  signal  which controls membrane  pcrrncability to ions. Wc  have 
proposed  that ACh  action on its mcrnbranc  receptor is in many  respects 
similar  to  the  action  of  regulatory  rnctabolitcs on  allostcric proteins 
(Changcux,  1966; Changcux, Thidry, Tung, and Kittcl, 1967; Karlin, 1967; 
Podlcski and Changcux,  1968). 
In this  paper wc shall attempt to discuss some problems related to the 
recognition of  ACh  in the excitable membrane  of the ccl clcctroplax (Schof- 
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feniels and Nachmansohn,  1957;  Higman,  Podleski,  and Bartels,  1964)  and 
to the molecular structures involved in this recognition. After a  first section 
of methodology,  we  shall  present  a  number  of experimental  observations 
directly related to this question. They were performed both in vivo with the 
isolated electroplax and in vitro with membrane fragments and pure proteins 
isolated from these membranes.  Some suggestions are proposed,  but  no de- 
finitive  conclusions  are  yet  available  about  the  identification  of the  ACh 
receptor. 
THEORY 
We shall designate by acetylcholine-macromolecular  receptor  (ACh-M-receptor) the 
macromolecule (or macromolecules) responsible for the specific recognition of 
ACh and which is  (or are) specifically involved in the permeability changes 
caused by ACh. 
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FIOLrI~ 1.  Diagrammatic rep- 
resentation  of  the  acetylcho- 
line  protomer.  It  comprises 
two  structural  entities:  the 
ACh-macromolecular  receptor 
(shaded area) endowed with the 
capacity  for  specific recog- 
nition  of ACh;  and  the ACh 
ionophore (clear area) involved 
in the selective  translocation of 
cations promoted by ACh bind- 
ing  to  the  ACh-M-receptor. 
Figure reprinted by permission  from 
S.  Jusgius  Symposium, Helsinki, 
November 1967. Elsevier  Publish- 
ing  Company,  Amsterdam, 
London, New York. 1968. 116. 
Two classes of compounds are effectors of the ACh-M-receptor: agonists or 
receptor activators like acetylcholine fin the presence of eserine), decamethon- 
ium,  phenyltrimethyl  ammonium,  etc.,  which  promote  the  permeability 
change,  and  antagonists  or  receptor  inhibitors  like  d-tubocurarine  and 
flaxedil which block the action of receptor activators and stabilize the mem- 
brane in its resting state. 
Agonists and antagonists bind  to  a  site  (or sites)  on the ACh-M-receptor 
that we shall refer to as the ACh-receptor site  (or sites)  (ACh-R-site).  On a 
given membrane or even on a given ACh-M-receptor there might exist several 
classes of distinct ACh-R-sites. 
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volved in the recognition of the agonists or antagonists, from those which ac- 
count for the passive translocation or transfer of ions through the membrane 
or "ionophores." Ionophore is used here in a  very general sense and includes 
any selective ion pathway, channel, or pore. The ionophores, the properties of 
which are under the control of the ACh-M-receptor,  are referred to  as  the 
ACh-ionophores.  The  complex  ACh-M-receptor  plus  ACh-ionophore  is  the 
ACh-protomer.  This definition does not imply any particular structural relation- 
ship between receptor and ionophore except their coupling. They might be 
borne by the same macromolecule, although it is very likely that they might be 
distinct polypeptidic or lipoproteic entities (Fig.  1). 
In this theory we propose that the translocation of ions and the binding of 
agonists operate through distinct sites of the AGh-protomer. Their coupling 
mediated by the ACh-protomer would then be an indirect or allosteric effect 
and would be analogous to the allosteric interactions observed between cata- 
lytic and regulatory sites in regulatory enzymes. These interactions would then 
be mediated by the ACh-protomer through some kind of reversible reorgani- 
zation  of its  three-dimensional  structure.  Such a  conformational transition 
might  be  analogous,  although  not  necessarily  identical,  to  the  allosteric 
transition of regulatory enzymes. It should be mentioned that these mecha- 
nisms concern the early events of the membrane response to agonist binding. 
They might be at the origin of a sequence of secondary ionic events mediated 
by a  variety of mechanisms including diffusible signals different from ACh. 
This theory accounts for a number of properties of the so-called ACh-recep- 
tor. First of all the distinction between ACh-ionophore and ACh-M-receptor 
accounts for the fact that ACh promotes a variety of different ionic events on 
different  membrane  systems  or  even  on  a  given  membrane  (reference  in 
Grundfest,  1966).  It  accounts  also  for  the  fact  that  the  same  ionic  events 
might be caused by ACh binding at sites structurally distinct; e.g., the mus- 
carinic or nicotinic receptors. 
A  characteristic prediction of the theory is that ACh-M-receptor and iono- 
phores might possibly be  separated  in  vitro  as  distinct  entities.  The ACh- 
protomer should be reconstituted from the isolated units. Another prediction 
concerns the conformational transitions  of the ACh-protomer.  One  should 
look for structural reorganization of excitable membranes in vivo and of mem- 
brane fragments isolated in vitro caused byACh binding. The "allosteric transi- 
tions" of regulatory enzymes might offer models for such changes of structure 
although the structural changes which accompany ACh binding on an excit- 
able membrane might present their own characteristics. 
Any attempt to identify the ACh-M-receptor is faced with a  difficult prob- 
lem of methodology. One should distinguish properties which are required, 
or necessary, for a  macromolecule to serve as a receptor from those which un- 
equivocally show that the considered rnacromolecule is indeed involved in the 228  s  EXCITABLE  MEMBRANES 
permeability changes caused by ACh. The capacity of recognition for ACh and 
its congeners  belongs to the first group of properties. However, the structural re- 
quirements for a compound to be an effector of the ACh-M-receptor are not 
extremely strict.  The  presence of quaternary  nitrogens is  essential  but  the 
three-dimensional organization of their carbon chain is of secondary impor- 
tance. This lack of strict specificity is an obvious difficulty for any attempt to 
identify the ACh-M-receptor. Since a  large spectrum of ACh derivatives are 
known to be pharmacologically active,  the apparent relative  "affinities"  of 
the compounds in vivo might fruitfully be compared with their affinity to the 
suspected macromolecule in vitro. However this test is ambiguous since the 
dissociation  constants  measured  in  vivo  are  not  thermodynamic  binding 
constants; in addition the dispersion in solution of the ACh-M-receptor might 
favor conformations of the macromolecule which are rare or even absent when 
the ACh-M-receptor is integrated into the membrane structure. The dissocia- 
tion constants of the isolated material measured in vitro might then be dif- 
ferent from the dissociation constants of the same material in vivo. Despite this 
problem a  fruitful  initial  approach  is  to  isolate from synaptic  membranes 
macromolecules which possess a  specificity of recognition for activators and 
inhibitors and whose binding constants are  as  close as  possible to  that  ex- 
hibited by the excitable membrane in vivo. The most direct technique to use 
is equilibrium dialysis (Changeux, Leuzinger, and Huchet, 1968; O'Brien and 
Gilmour,  1969). Another method is affinity labeling (references in Changeux, 
Podleski, and Wofsy, 1967). In this technique reagents are used which (a) are 
structural analogs of ACh and thus exhibit a high affinity for the binding site 
of ACh in the membrane; and (b) possess a highly reactive group which enable 
them to establish a covalent bond with amino acid side-chains located within 
the site or in its close vicinity. 
Such a reagent sould permit the labeling of the macromolecule (or macro- 
molecules) carrying the ACh-R-site. The major limitation of this technique is 
the nonspecific binding of these highly reactive compounds to sites which are 
unrelated to the ACh-R-site. 
In the course of this work we have extensively studied one of the very few 
proteins from the electroplax membrane which can be isolated and purified 
(Kremzner and Wilson, 1964; Leuzinger and Baker,  1967) and which possess, 
as well, the specificity of recognition of ACh and its congeners: the enzyme 
acetylcholinesterase. A number of similarities have been pointed out for many 
years between AChE and the ACh-M-receptor and the question  is whether 
or not AChE might have a double function? Would it show both: a  catalytic 
function; the hydrolysis of ACh at its active center and a regulatory function; 
the promotion of membrane permeability changes upon ACh binding at sites 
distinct from the active site? The direct involvement of AChE in permeability 
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troversial. Striking analogies between AChE and the ACh-M-receptor will be 
presented in this paper. However the evidence will still not be sufficient to let 
us conclude that AChE is directly involved in the electrogenic action of ACh. 
These structural  analogies might simply reflect a  common capacity for rec- 
ognition of ACh. 
Presence of "Regulatory"  Sites on AChE 
As  mentioned previously a  necessary  requirement for  a  macromolecule to 
play a  role as an ACh receptor is to present a  high affinity for ACh and the 
related neuromuscular blocking agents. Early kinetic studies with AChE from 
Torpedo marmorata, which have been largely confirmed with E. electricus enzyme, 
have shown that AChE is inhibited by a variety of  curare-like agents (Changeux, 
1966). These inhibitors belong to two distinct groups according to their mode 
of action on the enzyme. Members of the first group typified by decametho- 
nium,  a  receptor  activator,  act  as  classical  competitive inhibitors.  To  the 
second group belong flaxedil or d-tubocurarine, two typical receptor inhibitors, 
which only partially  inhibit the enzyme. The interpretation we have proposed 
for this partial  inhibition  is  that  flaxedil  and  the  substrate  can  be  simul- 
taneously bound to the enzyme; in other words their binding sites are, at least 
partially,  distinct.  In agreement with this  interpretation is  the observation 
that flaxedil  and  d-tubocurarine antagonize the inhibition by bisquaternary 
competitive inhibitors like decamethonium. These bisquaternary competitive 
inhibitors would bind both at the enzyme-active site and at sites topographic, 
ally distinct from the enzyme-active center that we have named "peripheral 
anionic centers." 
Of interest is the fact that some ligands like flaxedil assumed to bind pri- 
marily  to  these  peripheral  anionic  centers  potentiate  the  binding of other 
ligands, like 3-OH-phenyltrimethyl ammonium, to the active center. In other 
words the binding of ligands to the peripheral anionic centers might control 
the properties of the enzyme active center. The presence of this class of non- 
catalytic  sites on AChE  is of importance since previously when AChE was 
considered as  a  potential ACh-M-receptor,  it was always assumed that  the 
ACh-R-site was the active site of the enzyme. 
Affnity  Labeling  of the ACh-R-Site by  TDF In  Vivo 
Several  attempts  to  identify the ACh-R-site  with  affinity labeling reagents 
have already been published  (Takagi, Akao, and Takahashi,  1965; Gill and 
Rang,  1966). In our experiments we used as a label p-(trimethyl ammonium) 
benzene  diazonium fluoroborate  (TDF)  (Changeux,  Podleski,  and  Wofsy, 
1967),  a  compound which gave successful labeling of the active site of anti- 
p-azotrimethyl phenylammonium antibodies  (Fenton and Singer,  1965)  and 
of bovin  erythrocyte  ACh-esterase  (Wofsy  and  Michaeli,  1967).  TDF  is  a 23o  s  EXCITABLE  MEMBRANES 
structural analog of phenyltrimethyl ammonium, a  typical and potent recep- 
tor  activator,  but  in  addition possesses a  reactive  diazonium group  which 
forms a  covalent bond mainly with tyrosine, histidine, and lysine side-chains 
in  proteins.  Although it presents  striking  structural  analogies with phenyl- 
trimethyl ammonium, TDF is not a receptor activator. Exposure of the inner- 
vated face of the electroplax to TDF is not accompanied by any change of 
potential or resistance but by an irreversible loss of the sensitivity to receptor 
activators. TDF acts as an irreversible receptor inhibitor. Indeed, d-tubocur- 
arine and flaxedil, i.e.  typical receptor inhibitors,  and phenyltrimethyl am- 
monium, a  receptor activator,  reduces the reaction of TDF with the mem- 
brane. This protective effect is interpreted as being due to a  competition be- 
tween TDF and these effectors at the level of the ACh-R-site, a  further sug- 
gestion for the selective binding of TDF at the ACh-R-site. 
On the other hand, it was shown that agents known to alkylate irreversibly 
the esteratic center of AChE such as diisopropyl phosphorofluoridate (DFP) or 
diisopropyl  phosphorylthiocholine (phospholine)  do  not  interfere  with  the 
action of TDF on membrane excitation. This observation indicates again that 
the catalytic moiety of AChE active center does not directly contribute to the 
recognition of ACh in the early step of the cell response. (This question shall be 
more extensively discussed later.) 
Following the same approach, Karlin  and Winnik  (1968)  have  used,  as 
well, a derivate of phenyltrimethyl ammonium, but their reagent possesses as 
a  reactive  group  a  maleimide instead  of a  diazonium and  is  consequently 
assumed  to establish  covalent  bonds  with sulfhydryl residues.  It  blocks ir- 
reversibly the response to receptor activators at concentrations several orders 
of magnitudes lower than TDF but exclusively after exposure of the cell to 
dithiothreitol, a  disulfide bond-reducing agent. Both this result and the one 
obtained with TDF indicates that amino acid side-chains are constituents of 
the ACh-receptor site and strongly support the view that the membrane com- 
ponent which carries the site is a  protein. 
Finally we would like to present an experiment which shows the complexity 
of the problem we are dealing with.  In this experiment we compare the re- 
sponse of the  cell  to  two  different  receptor  activators,  carbamyleholine and 
decamethonium,  after  a  short  exposure  of the  membrane  to  TDF.  Fig.  2 
shows that  the maximal response of these two  activators  is  selectively and 
differentially altered following the pulse of TDF; in the present experimental 
conditions (see legend of Fig. 2) the maximal response to carbamylcholine is 
decreased by 50 % while the response to decamethonium is almost completely 
abolished. 
This  result  supports  the  conclusion  previously  established  on  different 
grounds the conversion of shape of the dose-response curve  (Changeux and 
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choline are, at least partially, distinct.  Consequently the ACh-M-receptor has 
to be viewed as a  complex structure.  It might  not simply be made  up  of a 
single  polypeptide  chain. 
Affinity Labeling of AChE by  TDF In  Vitro 
Since TDF  is,  in vivo,  an  affinity labeling reagent of the ACh-R-site we re- 
investigated with some detail the action of this compound, in vitro, on highly 
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LABELING AT  THE  ACTIVE SITE  AS first  shown  by Wofsy and  Michaeli 
(1967) with AChE from bovine erythrocytes, TDF is an irreversible inhibitor 
of ACh-hydrolysis. We confirmed this observation with eel AChE  (Meunier, 
1968;  Meunier  and  Changeux,  1969).  The  simplest  scheme  to  account  for 
AChE inhibition  in the absence of substrate is the following: 
kt  k= 
E+TDF~  (E--TDF)  ")IN  h 
where  (E--TDF)  is a reversible transition complex defined by its dissociation 
constant K~)~  =  k2/kl, IN an inactive apoenzyme, ks the rate constant of IN 
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Under  the  present  experimental conditions  where  the  concentration of 
active sites is small as compared with the concentration of TDF and where the 
formation of IN is assumed to be the rate-limiting step,  then, the kinetics of 
AChE inactivation by TDF are consistent with the proposed mechanism as 
long as the times of exposure are shorter than  1 rain and that the substrate 
used in the subsequent assay is a  polar substrate. As we shall see later this is 
no longer true for exposures of more than 1 rain and when a neutral substrate 
is used instead of a polar one. In first approximation, the kinetic of AChE in- 
activation is pseudomonomolecular and is  interpreted on the basis  of TDF 
binding directly at the level of the complex enzyme-active center. 
TABLE  I 
PROTECTION  BY  REVERSIBLE  INHIBITORS  OF  AChE  AGAINST 
THE  IRREVERSIBLE  INACTIVATION  OF THE  ENZYME  BY TDF 
Initial activity 
% 
No inhibitor  7.0 
Decamethonium  88.5 
d-Tubocurarine  46.0 
Flaxedil  43.0 
Hexamethonium  14.0 
Phenyltrimethyl ammonium  15.0 
Tetraethyl ammonium  8.0 
Methylquinolinium  7.5 
A  sample  of purified AChE  is exposed  for 5  rain  to 10  .4 M TDF  at 0°121 in 
5  X  10  -~ M Na phosphate buffered  at pH 7.0 in the presence or  the absence 
of the indicated  inhibitor,  the concentration  of which  was  always  10  -4  M. 
After 5 rain the mixture was diluted 200-fold  and assayed for AChE  activ- 
ity using acetylthiocholine as the substrate (Meunier and Changeux, unpub- 
lished results). 
According to Nachmansohn and Wilson  (1951)  AChE-catalytic site com- 
prises a  negatively charged "anionic center" and an "esteratic center." The 
question is then to what part of AChE-active center does TDF bind? Is it a 
specific labeling reagent of the anionic center? In order to answer this question 
we tested the action of several AChE inhibitors on the reaction of TDF with 
the enzyme (Meunier,  1968;  Meunier and  Changeux,  1969).  We used two 
classes of inhibitorsX: (a) Competitive inhibitors specific for the anionic center, 
e.g. tetramethyl ammonium and others containing quaternary nitrogens; and 
(b) Inhibitors specific of the esteratic center, e.g. phospholine. 
Table I  shows that reversible ligands of the anionic center protect the en- 
zyme against inactivation by TDF. The kinetic analysis of the interaction be- 
tween TDF and these positively charged inhibitors have shown that, within 
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TDF and the inhibitor is competitive for the establishment of the transitory 
Michaelis complex. 
As a test for the validity of the theory, we determined the dissociation con- 
stant  of one  of these  inhibitors:  decamethonium using both the  protection 
against TDF inactivation and reversible competitive inhibition of the enzyme 
activity. Exactly the same value was found--l.7  X  10  -6 M. 
The sum of these results indicate that TDF binds through its  quaternary 
nitrogen to the anionic center of the active site. The next question is then: is 
TDF binding at the active site restricted to the anionic center or does it in- 
volve, partially or completely, the esteratic center? 
In our approach to this question we studied the binding of TDF to the en- 
zyme after irreversible alkylation of the esteratic center by an organophos- 
phate: 0,0-diisopropyl-phosphorylthiocholine (phospholine). The binding of 
TDF  to  the enzyme, was followed under these conditions, either indirectly 
through  an  enzyme test  after  reactivation  of  the  phosphoryl  enzyme by 
pyridine 2-aldoxime methiodide (PAM) or directly, using *-H labeled TDF. 
It was shown that PAM no longer reactivates the phosphoryl enzyme after 
its exposure to TDF. TDF thus binds to the phosphoryl enzyme. Direct evi- 
dence in favor of this conclusion is obtained using tritiated TDF: the number 
of TDF molecules bound per molecule of enzyme is not changed after alkyla- 
tion by phospholine. Finally, as we shall see later, after an extensive reaction 
with TDF, the esteratic site is still operative and splits nonpolar substrates. It 
is thus concluded that the inactivation of AChE by TDF is caused by the ex- 
clusive binding of TDF to the anionic center. 
LABELING  AT  THE  REGULATORY  SITES  In  the  previous  paragraph  the 
evidence was presented that TDF covalently binds at the level of the active 
site; we shall discuss now some experimental findings which are interpreted on 
the basis of TDF covalent bonding to sites  distinct from the enzyme-active 
center (Meunier and  Changeux,  1969). 
The first suggestion comes from the fact that for times longer than  1 min 
the  kinetics  of  inactivation  of AChE  no  longer  follow  pseudo-first-order 
kinetics. The second is offered by the study of the effect of TDF on the hy- 
drolysis of a neutral substrate. 
In Fig. 3 are compared the effects of TDF on the catalytic activity of ACHE, 
using either a  polar  substrate  acetylthiocholine, ATCh,  or  a  neutral  one, 
indophenyl acetate.  In  this  experiment ACHE  solution is  supplemented at 
zero time with TDF  at  a  final concentration of 10-* M,  and  subsequently, 
samples are diluted at the indicated time and immediately assayed with both 
substrates. When ATCh is the substrate, as previously mentioned, a complete 
inactivation  occurs.  But  when  IPA  is  used,  the  activity  only  transiently 
decreases: a  slow reactivation follows the inactivation phase.  After 3  hr the 
activity measured is about 30o'/0 larger than the initial activity. 234  s  EXCITABLE  MEMBRANES 
The early inhibition phase, observed with ATCh and IPA, is accounted for 
by TDF bonding at the anionic site of the active center:  the  access  of both 
substrates to the esteratic site would be sterically hindered. 
Several hypotheses are proposed to explain the slow recovery of the catalytic 
activity towards IPA hydrolysis: (a)  a  spontaneous dissociation of an ACHE- 
TDF  complex;  (b)  a  slow structural reorganization of ACHE,  following the 
binding of a  first TDF molecule to the active site, e.g. the intramolecular mi- 
gration of bound TDF; and (c) the covalent bonding of additional TDF mole- 
cules to  peripheral  anionic  sites  distinct from the anionic  site  of the  active 
center. 
Hypothesis  (a)  does not  account for  the observation  that  the reactivated 
enzyme no  longer  hydrolyses polar  substrates  (i.e.  ATCh).  Additionally  a 
prediction of hypothesis (b)  is that the reactivation phase could take place in 
FIoryl~ 3.  Effect of TDF  on 
the activity of purified acetyl- 
cholinesterase. The  enzyme is 
exposed to 10  -4 M  TDF at zero 
time. Subsequendy the mixture 
IPA~  o'-t~'''-  is  diluted,  at  the  indicated 
~**  /"f  time,  and  assayed on  both  a 
I.C  .~  charged  substrate, acetylthio- 
choline (ATCh), and a neutral 
0..*  substrate,  indophenyl  acetate 
,...J°  (IPA). Figure reprinted by permis- 
~",a~,  t  ATCh  sion  from F. E. B. S. Letters, 1969, 
0  l  ~  ~-~'~2~  2." 224. 
hours 
the absence of TDF.  In order to test this second hypothesis unreacted TDF 
was, at the end of the inhibition phase (i.e. after about 10 min of incubation), 
either quenched by addition of an excess of histidine, or rapidly eliminated by 
filtration of the reaction mixture through a  Sephadex G-25 column. In both 
cases,  the reactivation rate was instantaneously decreased.  Inhibition of the 
slow phase was also obtained by adding, under the same conditions, an excess 
of decamethonium (Fig. 4).  In other words, the reactivation phase can be ex- 
plained on the basis of a secondary slow reaction between TDF and additional 
sites distinct from the active site. The simplest hypothesis to account for the 
reactivation process would be that binding of TDF to these "additional" sites 
promotes a  structural reorganization of the active site through indirect and 
thus "allosteric" interactions mediated through a conformational transition of 
the enzyme molecules. 
After  an  extensive reaction  with  TDF,  an  irreversibly modified  enzyme 
(M-AChE) is obtained, some properties of which differ markedly from those 
of the  native  enzyme  (ACHE).  The  M-AChE  hydrolyzes IPA  about  40 % CH.~o~trx,  PoDm~SVa, Am  M_~trNmR  Acetylcholinesterase and  the  AGh-M-Receptor  235  s 
faster than ACHE, although its ability to hydrolyze ATCh is almost completely 
lost. The M-AChE shows the same sedimentation coefficient (about  11 S) and 
the same apparent affinity for IPA (K~  =  8.3  X  10  -4 M) as the native enzyme. 
But, its sensitivity to the bisquaternary ammonium inhibitor decamethonium 
+  +  i  (Deca)mMe3~(CH2)10~Me3  P  s  markedly  altered.  As  illustrated  on  Fig.  5, 
Deca inhibits the splitting of IPA by the native protein, but not by the modi- 
fied enzyme. 
The  sum of these results  is  in  agreement with the presence on  AChE  of 
specific  sites  for  quaternary  nitrogens,  which  are  topographically  distinct 
from the anionic site of the active center. This conclusion is of importance 
since,  as we have seen it before, TDF  is  an  affinity labeling reagent of the 
ACh-M-receptor, in vivo. 
._~_~l  Deca  (0 rain)  ,._...e P-'e- 
• 
Deca  (Brain)  0.5]~.~. 
0  /  ,  ,  w  s~  2_ 
0  i  2  3  ~0 
hours 
Floum~  4.  Selective  blockade 
of the  two  phases  of TDF  ac- 
tion on AChE by 10  -8 M deca- 
methonium  (Deca) (Meunier 






FIGURE  5.  Abolition  of  the 
sensitivity of  acetylcholinester- 
treated  AChF 
. ....  --o-.--  ase  to  deeamethonium  (Deca) 
inhibition by a 3 hr exposure to  I& 
\  10  -4 M TDF. The substrate was 
"~'~,  n~ve  AChE  ,----f  indophenylacetate.  Figure  re- 
printed  by permission from  F.  E. 
k-Am 
01025M  tff~M  "1~  B.  S.  Letters, 1969,  2: 224. 
[Pats] 
NUMBER  OF  TDF-BINDINO SITES  PER  MOLECULE  OF  Ache  AND  A  MODEL  OF 
STRUCTUI~ OF AChe  Since TDF binds covalently to sites specific for quater- 
nary nitrogens on ACHE, quantitative estimates of the number of TDF mole- 
cules bound per molecule of enzyme should give essential information on the 
structure of the enzyme and on its symmetry properties. We used radioactive 
TDF and pure AChE to count the sites (Meunier, Lenzinger, and Changeux, 
1969). First of all we consider as "specific," the molecules of TDF the covalent 
binding of which is prevented by an excess of decamethonium. In order to 
identify the sites to which TDF  is specifically bound we used the following 
graphic  representation.  Whe  fractional  inactivation  of  the  enzyme,  using 236  s  EXCITABLE  MEMBRANES 
ATCh as a substrate, is plotted as a function of the number of TDF molecules 
bound. We have shown that this curve is biphasic. The first part of the curve 
from 0  to 90 % inactivation is almost linear and extrapolates to a  number of 
2.12  sites per molecule of AChE assuming a  molecular weight for AChE of 
2.6  X  105 daltons. The loss of activity corresponding to the remaining 10 % is 
obtained when, at least,  two additional sites are filled. This shape of curve is 
readily interpreted on the basis of TDF binding to the two distinct classes of 
sites mentioned earlier. The dramatic loss of activity on a  polar substrate,  is 
interpreted as due to the binding of TDF to the active sites. The residual drop 
of activity on a polar substrate, corresponds, in the time scale, to the slow phase 
of reactivation observed with a neutral substrate: it is interpreted as caused by 
the binding of TDF to the "regulatory sites." There would thus be two cata- 
lytic sites plus a minimum of two regulatory sites per AChE molecule of 2.6  × 
105 mol wt. 
Presence of a twofold symmetry in the number of sites is further suggested by 
equilibrium dialysis experiment performed with decamethonium, a bisquater- 
nary competitive inhibitor of the enzyme. Here again two main binding sites are 
found per AChE  molecule  (Meunier,  Leuzinger,  and  Changeux,  1969)  the 
same result is found as well with specific labeling reagents of the esteratic sites 
(W.  Leuzinger, personal communication). 
These results on the number of sites are consistent with those obtained on 
the molecular weight of the native enzyme and of its subunit.  According to 
Leuzinger,  Goldberg,  and  Cauvin  (1969)  AChE  molecule  is  made  up  of 
two  different polypeptide chains of the same molecular weight (6.5  X  104) and 
contains two sets of each kind. By analogy with hemoglobin it can be named an 
o~s~2-dimer. The question we ask now is what are the respective roles of the two 
different classes of subunits? One proposal is that one of the two classes of sub- 
units is endowed with a  catalytic function and carries the esteratic sites,  and 
that the subunit of the other class, carries the regulatory sites; i.e., is a regula- 
tory subunit. An alternative interpretation is that the two different moieties 
of AChE-catalytic site,  e.g.  the anionic center in the one hand,  the esteratic 
site on the other hand, are borne by different chains. In other words the dif- 
ferentiation of the  active  site would reflect a  differentiation of the constitu- 
tive  chains  of the  enzyme.  Discrimination  between  these  two  alternatives 
should readily be made by separating the chains and identifying their sites. 
A  virtue of the first interpretation is that it gives a  molecular basis for an 
eventual role of AChE as an ACh-M-receptor. The two functions of the en- 
zyme would be carried by different polypeptide chains; the regulatory sub- 
unit would be responsible for the recognition of  ACh as a regulatory signal and 
the  subsequent  promotion  of  permeability  changes,  the  catalytic  subunit 
would account for the destruction of the regulatory signal and thus permit the 
repetitive stimulation of the synapse. CHANGEUX, PODLESKI, AND  M~.UNmR  Acetylcholinesterase  and  the  ACh-M-Receptor  237  s 
Effect  of  Dithiothreitol  on  the  Reaction  of  TDF  with  AChE  and  with  ACh 
Receptor 
In the past few years Karlin  and  associates have compared the effects of a 
variety of sulfhydryls reagents and of disulfide bond-breaking agents on both 
AChE and the eleetroplax preparation (Karlin and Bartels,  1966; Karlin, 1967; 
Karlin and Winnik,  1968). 
They showed for instance that exposure  of the cell to dithiothreitol, dramatic- 
ally alters its response to both receptor activators and receptor inhibitors but 
has  no  effect on AChE activity assayed  in  vitro.  From  these  observations 
they concluded that  AChE  and  the ACh-M-receptor were distinct macro- 
molecular entities.  We have reinvestigated this  point with more detail  using 
TDF  as a  probe  (Podleski, Meunier, and Changeux,  1969). 
-IOC 
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10"6M  TDF 
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Pmu~  6.  Reversible changes of potential and resistance of the electroplax membrane 
promoted by  10  -6 M TDF after a  10 rain exposure to  10  -3 M dithiothreitol.  P., empale- 
merit; P, Ringer's solution supplemented with 5  X  10  "~ M Na phosphate pH 5.7; h, 
10  -3 ~  1-histidine in pH 5.7 Ringer's solution to quench unreacted TDF. E, potential 
in miUlvolt, R, resistance measured following the technique described by Podleski and 
Changeux, 1969 b. Figure reprinted by permission from Proc. Nat. Acad. Sci. U.S.A.,  1969, in 
press. 
Fig.  6  shows that a  treatment of the innervated face of the electroplax by 
DTr  is accompanied by a remarkable modification of its reaction with TDF. 
Although an irreversible inhibitor in the normal cell, TDF becomes a revers- 
ible  activator  in the DTT-treated  cell.  Moreover in vitro  exposure of pure 
AChE to DTT is also accompanied by a change of its reactivity to TDF. TDF 
no longer acts as an irreversible inhibitor of DTT-treated AChE: it becomes a 
reversible competitive inhibitor of the enzyme. Under these conditions, the Ki 
for TDF as a  reversible inhibitor is found the same (2  X  10  -s M) as the dis- 
sociation constant measured for the establishment of the reversible Michaelis 
complex in the first step of the affinity labeling of the native enzyme. DTT ~38 s  EXCITABLE  MEMBRANES 
treatment thus impairs the establishment of the covalent bond between TDF 
and some residue of the enzyme-active site.  DTT treatment modifies both the 
sensitivity of the electroplax membrane in vivo and the reactivity of AChE 
in vitro. Instead of supporting the distinction between AChE and the ACh M- 
receptor,  the  present  experiments  with  DTT  suggest  their  similarity.  It 
should be emphasized however that their  identity cannot be established on 
this basis. 
Binding of ACh to AChE in the Presence of Eserine 
The ACh receptor binds ACh. But AChE is present in large amounts in the 
electric organs and splits ACh at an extremely fast rate. It thus seems hardly 
possible to demonstrate ACh binding in vivo, as well as in vitro under such 
circumstances. It is an old pharmacological observation however that ACh 
sensitivity is preserved and more often potentiated in the presence of specific 
inhibitors of AChE like eserine, diisopropyl phosphorofluoridate and various 
organophosphates such as paraoxon, phospholine, methane sulfonyl fluoride, 
etc. This fact is of importance since it shows that the irreversible alkylation of 
AChE-esteratic site  does not  block  the response of the membrane to  cho- 
linergic agents and consequently that the esteratic site of the enzyme is not 
part of the ACh-R-site. This proposition has been well documented with the 
electroplax preparation (Podleski,  1967) for a variety of activators, in partic- 
ular for 3-OH  phenyltrimethyl ammonium a  compound known to interact 
with AChE-esteratic center through its 3-OH residue. Neither the shape nor 
the position of the dose response curve to the activators tested are significantly 
modified by the irreversible acylation of AChE-esteratic site. 
Should  we  conclude from  these  observations  that  the  protein  AChE  is 
not the ACh-R-macromolecule? This would be the case if we were able to 
show that once the AChE-esteratic site is  blocked by eserine or DFP  then 
the enzyme no longer binds ACh and its  derivative. First of all,  as already 
mentioned, TDF,  an affinity labeling reagent of the ACh-R-site, does bind 
to AChE when the seryl group of its  esteratic site  is  aikylated by a  diiso- 
propyl  phosphoryl residue.  Moreover as  we  shall  see  now ACh  itself,  the 
physiological transmitter, does interact with AChE in the presence of eserine 
(Changeux, Leuzinger, and Huchet, 1968). 
This was shown using the simple technique of equilibrium dialysis which 
let Gilbert and Mtiller-Hill (1966)  identify the genetic repressor of the Lac- 
operon. We started using membrane fragments purified from the innervated 
face of the electroplax (Changeux, Israel, Gautheron, and Podleski, 1969) and 
14C acetylcholine labeled on its acetyl group. In the presence of 10  -5 r~ eserine 
or  10  -8 M phospholine,  the radioactivity accumulates inside the bags  con- CI-IANOEUX, PODLESKI, AND  MEUNIER  Acetylcholinesterase and  the  ACh-M-Receptor  239  s 
mining the membrane fragments. Although an unambiguous physicochem- 
ical interpretation for this accumulation has not yet been proposed we shall 
say  that  ACh  "binds"  reversibly  to  the  membrane  fragments.  The  com- 
ponent which accounts for this binding is thermostable, resists to pancreatic 
lipase,  trypsin, and chymotrypsin but is digested by pronase.  It is a  protein. 
In  order  to  identify this  protein we  centrifuged membrane fragments dis- 
solved in  1% deoxycholate on top of a  sucrose gradient established in 10  -8 
Na  phosphate  pH  7.0  supplemented  with  1%  deoxycholate.  Both  ACh 
binding  and  AChE  activity  were  assayed  in  each  fraction  collected  after 
';  U  I  Top 
i  s  ,oo  
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FIoum~ 7.  Sedimentation in sucrose gradient of membrane fragments treated with 1% 
deoxycholate. Sodium deoxycholate is first added at room temperature for a few minute8 
to the suspension of membrane fragments in sucrose containing 9.2 mg protein per milli- 
liter. The mixture is then dialyzed against 1% deoxycholate in  10  -a M Na phosphate, 
pH 7.0, for 1 hr and added on top of a sucrose gradient stabilized in 10  -3 M  Na phosphate, 
pH 7.0, supplemented with 1% deoxycholate. The gradients are centrifuged for 4 hr at 
50,000 rpm in a  SW 65 rotor in a  Beckman Spinco preparative ultracentrifuge. AChE 
and ACh binding in the presence of 10  -5 M eserine are measured in each fraction. Initial 
rates  of acetylthiocholine hydrolysis (o~) are  expressed  in  millimoles per  minute  per 
microliter of fraction. Figure reprinted by permission from F. E, B. S. Laters,  1968, 2: 77. 
centrifugation. As shown on Fig. 7 both the ACh-binding protein and AChE 
sediment at exactly the same velocity. 
We therefore tested the binding of ACh to pure AChE prepared from elec- 
tric tissue and found, indeed, that the pure protein binds ACh in the pres- 
ence of 10-"M eserine. 
A  striking quantitative feature of ACh binding to AChE is that, under the 
present experimental conditions the binding curve does not follow a  simple 
Langmuir isotherm:  there  is no tendency for  saturation  at  high ACh con- 24o s  EXCITABLE  MEMBRANES 
centration;  above  10-6~-free  ACh  the  amount  of  bound  ACh  increases 
almost  linearly with  the  concentrations of free ACh;  the  Scatchard  plot 
of the binding data is not linear and does not extrapolate to a finite number 
of sites at infinite ligand concentration (Fig.  8). 
At  high  ACh  concentrations the  number of ACh  molecules bound  per 
molecule of AChE becomes remarkably large. Values up to several hundreds 
are  counted.  The  magnitude of the  number  of ACh  molecules bound  in 
.....  put. AChE  /  [ 
~4  200 
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-  /  "~2  I00 
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Fmuvm 8.  Binding of ACh to membrane fragments and pure AChE both from electric 
tissue. ACh bound per gram protein is plotted as a function of free ACh concentrations 
(membrane fragments), racer is the number of ACh molecules bound per molecule of 
pure AChE  (tool  wt  =  2.6  X  10  s)  (Leuzinger, Goldberg, and Cauvin,  1969),  and 
[ACh] is  the free concentration of ACh  expressed  in moles  per liter. AChE concen- 
trations are estimated spectrophotometrically (e  =  16.1 (Leuzinger, Baker,  and Cau- 
vin, 1968)),  chemically (Folin reaction, and Biuret),  and by enzyme assay.  Figure re- 
printed by permission from F. E. B. S. Letters, 1968,  2:  77. 
these conditions seems somewhat paradoxal in connection with our present 
knowledge of AChE  quaternary structure  and  binding  sites.  This  unique 
property of AChE has not yet received a  reasonable physicochemical inter- 
pretation. 
Of importance is the observation that this unusual capacity for ACh bind- 
ing appears to bca  specific property of ACHE.  First of all,  the amount of 
ACh bound by the membrane fragments is integrally accounted for by their 
content in AChE estimated through an enzyme test  (about 5 % w/w of the 
1 Note Added in Proof.  Recent experiments have shown that much less displacement of radioactivity 
occurs when acetylcholine  labeled on the methyl group is used instead of 14Cl-acetylcholine. The 
process seems to be complex and might involve a covalent reaction in addition to reversible binding. CHANGEUX, PODLESKI, AND  MEI.INIER  Acetylcholinesterase and the  ACh-M-Receptor  o4 x s 
total  protein).  Furthermore four  unrelated  proteins tested  under  the  same 
conditions,  serum albumin,  ~-galactosidase,  ribonuclease,  and  catalase,  do 
not  show  any  significant binding of ACh.  Another  important fact  is  that 
ACh  bound  to  AChE  is  itself displaced  by  compounds pharmacologically 
active on the electroplax preparation such as decamethonium, d-tubocura- 
fine, and flaxedil. ACh binding is also considerably reduced in the presence 
of high  salt  concentrations  (10-1M NaC1)  or  negatively charged detergents 
(1% Na deoxycholate). The binding of ACh in the presence of eserine seems 
thus  to  involve  a  special  class  of sites,  distinct from  AChE-catalytic  sites, 
which present a  high affinity for curare-like agents and the positive charge 
of ACh molecule seems essential for the interaction of ACh with these sites. 
In order to identify these ACh-binding sites we studied the effect of TDF 
0d  ,  ,  ,  ,  --  -- 
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FIOURE 9.  Comparative effects of TDF on AChE activity assayed on a neutral substrate 
(indophenylacetate)  •- •,  and ACh binding in  the  presence of eserine  measured  by 
equilibrium dialysis,  ×-x. At zero time a solution of AChE in 5  X  10  -~ ~ Na phosphate 
buffer pH 7.0 is supplemented with 10  -4 M TDF; at the indicated times samples  of the 
mixture are made I0  -a M with 1-histidine to block unreacted TDF. Then IPA hydrolysis 
and ACh binding are assayed as described previously. 
on  ACh  binding  to  AChE  in  the  presence  of eserine.  The  reaction  with 
TDF  was  followed by  IPA  hydrolysis.  It was  of interest  to  test  (a)  if the 
capacity  to  bind  ACh  was  abolished  after  exposure  to  TDF,  and  (b)  in 
the positive case if the loss of ACh binding corresponds to the fast inactiva- 
tion phase or  to  the slow reactivation. 
FIG.  9  shows  that  exposure  to  TDF  is  accompanied by  a  dramatic  loss 
of its ability to bind ACh and that the kinetics of this decay does not follow 
the first rapid  phase of enzyme inactivation.  The  irreversible  inhibition of 
ACh-binding sites is thus unrelated to the binding of TDF  to AChE active 
center.  On  the other hand  this kinetic follows grossly the slow reactivation 
phase that we interpreted as due to the binding of TDF to "regulatory sites" 
distinct from AChE-active sites. This result is in agreement with our initial 
hypothesis that  there  exist  AChE-binding sites  for  quaternary  ligands  dis- 
tinct from the anionic site of the active center. 242  s  EXCITABLE  MEMBRANES 
DISCUSSION 
In this paper we have compared a  few properties of AChE isolated in vitro 
with  those  of the ACh-rcceptor  expressed  by  the  in  vivo  response  of the 
e|ectroplax  membrane.  Aware  of  the  fact  that  a  number  of  theoretical 
and  practical  difficulties are  inherent in such a  comparison, we may sum- 
marize the main conclusions as  follows: 
I.  Blockage of the  esteratic  center of AChE  does  not alter  the response 
of the cell to receptor activators.  Consequently the esteratic center of AChE 
is  not involved in  the  early recognition step which is  at  the origin of the 
permeability changes caused by ACh and its congeners. 
2.  AChE strongly binds compounds which are known to be potent effec- 
tors  of the electroplax membrane; e.g.,  phenyltrimethyl ammonium, deca- 
methonium, as receptor activators,  d-tubocurarine,  and flaxedil  as receptor 
inhibitors,  or  TDF an aifinity labeling reagent of the ACh-R-site  in  vivo. 
It is concluded that there exist on AChE molecule binding sites for quaternary 
ligands: peripheral anionic centers, or regulatory sites, which are topograph- 
ically distinct from the anionic center of the active site. 
3.  A  disulfide  bond-breaking  agent,  dithiothreitol  (DTT),  alters  in  a 
parallel manner the reaction of AChE  and  the excitable membrane of the 
electroplax with TDF.  The  irreversibility of action of TDF  is lost,  in both 
cases,  after  exposure  to  DTT.  Both AChE  and  the  ACh-M-receptor  thus 
contain disulfide bonds. 
4.  In the presence of inhibitors of its  esteratic  center such as  eserine or 
phospholine,  AChE  binds,  in  vitro,  the  physiological  transmitter:  acetyl- 
choline. This binding primarily involves the regulatory sites located outside 
the active site. 
From these observations no definitive conclusion concerning the nature of 
the  ACh-macromolecular  receptor  can  be  proposed.  An  interesting  hy- 
pothesis is that the regulatory sites present on AChE molecules might play 
a  physiological role  as  ACh-R-sites.  This  hypothesis  is  supported  by  the 
observation that AChE contains two classes of subunits and that one of them 
might  be  a  noncatalytic  subunit.  The  noncatalytic  subunit  would  then 
represent  a  "regulatory"  subunit  specialized  in  the  electrogenic  action  of 
ACh. We wish to emphasize however that this hypothesis does not exclude 
the  possibility  that  proteins  different  from  AChE-catalytic  or  -regulatory 
subunits  might  be,  or  contribute  to,  the  ACh-macromolecular  receptors. 
Accounting for the evidence that there might be several classes of ACh-R- 
sites  even  in  a  system  as  simple  as  the  electroplax,  the  question  remains 
whether or not the "regulatory" sites present on AChE might be one of them? 
In any case, it is clear that the ACh-M-receptor and AChE are closely re- CHANGE  UX,  PODLESKI, AND  MEUNIER  Acet)lcholinesterase  and  the  ACh-M-Receptor  243  s 
lated  proteins.  The  distinction  between  both  classes  of  structures  will  thus 
require  a  careful  physicochemical  analysis  and  possibly  a  comparative 
sequence  analysis  of the  suspected  polypeptide  chains. 
The  observed  analogies  between  AChE  and  the ACh-M-receptor  might be 
unrelated  to the  electrogenic  function of ACh  and  simply due  to the fact that 
they  both  show  a  common  specificity  of recognition  for  ACh.  Even  in  this 
case,  this  approach  will  have  been  fruitful  since  it  already  let  us  find  some 
original  properties  of AChE  and  the  ACh-receptor. 
Research  in the  Department of Molecular  Biology at  the  Pasteur  Institute, has  been  aided  by 
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Scientifique  et Technique", the "Centre National de  la Recherche  Scientifique"  and the "Com- 
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